MoneyWorks4Me

Kopran - Quaterly Results

27 May 2022 Evaluate
A minor change in the total revenue was seen in the March 2022 quarter. The total revenue for the quarter stood at Rs. 645.03 millions against Rs. 619.65 millions during year ago period.The Company's Net profit for the March 2022 quarter have declined marginally to Rs. 47.73  millions as against Rs. 56.38 millions reported during the corresponding quarter ended.A decline of 89.61 millions was observed in the OP in the quarter ended March 2022 from 92.89 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 645.03 619.65 4.10 2045.20 2228.33 -8.22 2045.20 2228.33 -8.22
Other Income 21.24 22.33 -4.88 80.27 104.14 -22.92 80.27 104.14 -22.92
PBIDT 89.61 92.89 -3.53 234.40 406.14 -42.29 234.40 406.14 -42.29
Interest 7.97 5.36 48.69 29.53 38.07 -22.43 29.53 38.07 -22.43
PBDT 81.64 87.53 -6.73 204.87 368.07 -44.34 204.87 368.07 -44.34
Depreciation 10.61 10.46 1.43 43.23 41.03 5.36 43.23 41.03 5.36
PBT 71.03 77.07 -7.84 161.64 327.04 -50.57 161.64 327.04 -50.57
TAX 23.30 20.69 12.61 44.20 92.33 -52.13 44.20 92.33 -52.13
Deferred Tax 1.67 6.86 -75.66 6.73 34.76 -80.64 6.73 34.76 -80.64
PAT 47.73 56.38 -15.34 117.44 234.71 -49.96 117.44 234.71 -49.96
Equity 482.12 432.52 11.47 482.12 432.52 11.47 482.12 432.52 11.47
PBIDTM(%) 13.89 14.99 -7.33 11.46 18.23 -37.12 11.46 18.23 -37.12
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..